Recombinant Bordetella avium Monofunctional biosynthetic peptidoglycan transglycosylase, referred to here as mtgA, is a recombinant protein derived from the bacterium Bordetella avium. This enzyme is crucial for the synthesis of peptidoglycan, a key component of bacterial cell walls. The recombinant form of this enzyme is produced in various hosts such as Escherichia coli, yeast, baculovirus, or mammalian cells, primarily for research purposes .
mtgA is involved in the biosynthesis of peptidoglycan, which provides structural integrity to the bacterial cell wall. This enzyme catalyzes the formation of the glycosidic bonds between the sugar moieties of peptidoglycan, a process essential for bacterial growth and survival. Understanding the function of mtgA can provide insights into potential targets for antibacterial therapies, as disrupting peptidoglycan synthesis can inhibit bacterial growth .
Bordetella avium is a Gram-negative coccobacillus belonging to the phylum Proteobacteria. It is an obligate aerobe and is known for being fastidious to culture. This bacterium can infect humans and is part of a genus that includes well-known pathogens like B. pertussis, B. parapertussis, and B. bronchiseptica .
Research on mtgA from Bordetella avium is primarily focused on understanding its role in peptidoglycan synthesis and its potential as a target for developing new antimicrobial agents. The recombinant form of this enzyme is used in research settings to study bacterial cell wall assembly and to explore novel therapeutic strategies against bacterial infections.
| Characteristics | Description |
|---|---|
| Source | E. coli, Yeast, Baculovirus, Mammalian Cells |
| Target | Bordetella species |
| Function | Monofunctional biosynthetic peptidoglycan transglycosylase |
| Applications | Research into bacterial cell wall synthesis and antimicrobial targets |
| Purity and Storage | Typically high purity; stored under conditions to maintain stability |
KEGG: bav:BAV3005
STRING: 360910.BAV3005
Monofunctional biosynthetic peptidoglycan transglycosylase (mtgA) in Bordetella avium serves as a glycan polymerase, catalyzing the polymerization of peptidoglycan glycan strands during bacterial cell wall synthesis. The enzyme functions specifically by forming glycosidic bonds between N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM) subunits to create the peptidoglycan backbone. This process is essential for maintaining bacterial cell wall integrity and structural stability. Unlike bifunctional penicillin-binding proteins (PBPs), mtgA performs only the transglycosylase function without peptide cross-linking activity, making it a specialized component in the peptidoglycan synthesis machinery .
To study mtgA function experimentally, researchers typically use radiolabeled or fluorescently-tagged lipid II substrates to monitor glycan strand formation in vitro. Complementary approaches include gene knockout studies followed by phenotypic analysis of cell morphology, growth rates, and susceptibility to osmotic stress or cell wall-targeting antibiotics. These methodologies help elucidate the specific contribution of mtgA to Bordetella avium cell wall biogenesis and bacterial survival.
Recombinant Bordetella avium mtgA is typically expressed as a His-tagged fusion protein in E. coli expression systems. The full-length protein (amino acids 1-240) contains the complete functional domains, including the catalytic domain and transmembrane segment . The expression process generally follows these methodological steps:
Clone the mtgA gene (BAV3005) into an expression vector with an N-terminal His-tag
Transform the construct into an appropriate E. coli strain (commonly BL21(DE3))
Induce protein expression using IPTG at optimal concentration and temperature
Harvest cells and lyse using appropriate buffer systems containing detergents to solubilize the membrane-associated protein
Purify using nickel affinity chromatography, exploiting the His-tag
Perform size exclusion chromatography for further purification if needed
The purified protein is typically stored as a lyophilized powder or in a Tris/PBS-based buffer with 6% trehalose at pH 8.0 to maintain stability . For long-term storage, adding glycerol to a final concentration of 50% and storing at -20°C/-80°C in aliquots is recommended to prevent repeated freeze-thaw cycles that could compromise enzyme activity.
The transmembrane (TM) segment of mtgA plays multiple critical roles in enzyme function beyond simple membrane anchoring. Research indicates that full-length mtgA with its transmembrane segment demonstrates significantly higher enzymatic activity compared to truncated forms lacking this domain . The TM segment contributes to:
Proper orientation of the catalytic domain relative to the peptidoglycan synthesis machinery
Enhanced substrate accessibility by positioning the enzyme at the interface where lipid II substrates are presented
Potential interactions with other membrane-associated cell wall synthesis proteins
Influence on substrate specificity and binding affinity
Methodologically, comparing the activity of full-length versus truncated mtgA variants reveals that the TM segment "may play a role in substrate and moenomycin binding and in the GT reaction" . This phenomenon is consistent with observations in other peptidoglycan synthesis enzymes, such as PBP1b, where the TM segment similarly affects enzymatic activity. Research approaches to investigate this aspect include detergent solubilization studies, reconstitution in membrane mimetics (nanodiscs, liposomes), and site-directed mutagenesis of TM residues to identify specific functional contributions.
Measuring mtgA transglycosylase activity in vitro requires specialized approaches due to the membrane-associated nature of both the enzyme and its lipid II substrate. Several methodological strategies can be employed:
Radiolabeled substrate assay: Using lipid II substrates containing 14C or 3H-labeled GlcNAc to monitor incorporation into glycan chains, followed by separation of products using paper chromatography or SDS-PAGE and detection by autoradiography or scintillation counting.
Fluorescence-based assays: Employing dansylated or fluorescently-labeled lipid II analogues that exhibit altered fluorescence properties upon polymerization, allowing real-time monitoring of transglycosylase activity.
HPLC analysis: Separating and quantifying reaction products using specialized columns that can resolve different-length glycan chains.
Mass spectrometry: Characterizing reaction products by their molecular weights to determine chain lengths and modifications.
Moenomycin displacement assays: Using the competitive binding of the natural product moenomycin, which inhibits transglycosylases by mimicking their reaction transition state.
| Method | Advantages | Limitations | Detection Sensitivity |
|---|---|---|---|
| Radiolabeled substrate | Direct measurement of catalytic activity | Requires radioactive handling facilities | High (pmol range) |
| Fluorescence-based | Real-time kinetics, no radioactivity | Requires specialized substrate synthesis | Moderate (nmol range) |
| HPLC analysis | Detailed product characterization | Lower throughput | Moderate (nmol range) |
| Mass spectrometry | Precise molecular characterization | Expensive equipment, lower throughput | High (pmol range) |
| Moenomycin displacement | Simple binding assay | Indirect measurement of activity | Moderate (nmol range) |
For optimal results, it's recommended to use detergent-solubilized full-length mtgA with its transmembrane segment intact, as truncated forms show reduced activity . The choice of detergent is critical, with mild non-ionic detergents like DDM or CHAPS often providing the best balance between protein stability and activity.
Investigating mtgA substrate specificity requires sophisticated biochemical and analytical techniques to understand the enzyme's preference for natural and modified substrates. Methodological approaches include:
Structure-activity relationship (SAR) studies: Using chemically modified lipid II variants to systematically probe the structural requirements for substrate recognition, including alterations to the:
Lipid chain length and composition
MurNAc-peptide stem structures
Sugar moieties (NAG/NAM)
Phosphate linker region
Competitive substrate assays: Measuring the relative rates of incorporation when presenting multiple substrate variants simultaneously to assess preference.
Kinetic parameter determination: Calculating Km, Vmax, and kcat values for different substrates to quantify relative affinities and processing efficiencies.
Product analysis: Characterizing the glycan chains produced using different substrates to determine if substrate structure affects product length or pattern.
Cross-species substrate utilization: Testing whether mtgA can process lipid II from different bacterial species to understand evolutionary conservation of substrate recognition.
The transmembrane segment of mtgA has been shown to influence substrate interactions , suggesting that membrane composition and physical properties may also affect substrate specificity. This can be investigated using reconstitution in different lipid environments (varying in charge, fluidity, and composition) to observe effects on activity and substrate preference.
Results from these studies not only provide fundamental insights into mtgA biochemistry but also inform potential strategies for developing selective inhibitors that could target specific bacterial species while sparing others.
When faced with contradictory experimental results regarding mtgA function or properties, researchers should employ a systematic approach to identify the source of discrepancies and resolve contradictions. This process involves:
Detailed experimental condition comparison: Create a comprehensive table documenting all relevant experimental parameters across studies, including:
Protein construct details (full-length vs. truncated, tag position, linker sequences)
Expression system and purification methods
Buffer composition, pH, and temperature conditions
Substrate preparation methods and purity
Detergent types and concentrations
Analytical methods and their sensitivity ranges
Independent verification with multiple methods: Employ orthogonal techniques to confirm key findings, reducing method-specific artifacts.
Biological context consideration: Analyze whether differences might reflect genuine biological variability rather than experimental error, such as strain-specific adaptations or regulatory mechanisms.
Statistical analysis of contradictions: Apply techniques similar to those described in search result , which discusses methods for detecting factual contradictions. This includes:
Scoring the degree of contradiction between findings (on a scale of 1-5)
Using natural language inference (NLI) models to identify specific contradicting atomic facts
Contextualizing contradictions within the broader experimental framework
Collaborative resolution: When possible, engage with authors of contradictory studies to jointly investigate discrepancies through shared protocols or materials.
A structured approach for analyzing contradictions should decompose complex experimental results into "atomic facts" that can be individually evaluated, similar to the approach described for detecting contradictions in narratives . This allows precise identification of where contradictions occur and facilitates targeted investigation of those specific aspects.
Robust experimental design for studies involving recombinant Bordetella avium mtgA requires comprehensive controls to ensure valid and interpretable results. Essential controls include:
Enzyme activity controls:
Positive control: Known active transglycosylase (e.g., E. coli PBP1b) with established activity profile
Negative control: Heat-inactivated mtgA protein to establish baseline measurements
Catalytic mutant: mtgA variant with mutations in catalytic residues to confirm specificity of observed activity
Protein quality controls:
SDS-PAGE analysis to confirm purity and molecular weight
Western blot using anti-His antibodies to verify integrity of the recombinant protein
Mass spectrometry to confirm protein identity and detect potential modifications
Circular dichroism to assess proper protein folding
Substrate controls:
Substrate-only reactions to monitor spontaneous reactions or degradation
Known substrate analogs with established reactivity profiles
Lipid II preparations from different sources to assess substrate source effects
Inhibition and specificity controls:
Moenomycin treatment as a specific transglycosylase inhibitor control
Buffer components without protein to rule out non-enzymatic catalysis
Detergent concentration series to determine optimal conditions
Metal chelators (EDTA/EGTA) to assess metal-dependence of activity
Transmembrane domain controls:
These controls should be systematically incorporated into experimental designs and explicitly reported in publications to facilitate interpretation and reproducibility. The selection of specific controls should be tailored to the particular research question and methodological approach being employed.
Site-directed mutagenesis represents a powerful approach for dissecting the structure-function relationships within Bordetella avium mtgA. A comprehensive mutagenesis strategy should target multiple functional domains and utilize the following methodological approach:
Target selection based on structural and sequence analysis:
Conserved catalytic residues identified through multiple sequence alignment across species
Residues predicted to interact with substrates based on homology models
Transmembrane domain residues that may influence enzyme positioning and activity
Interface residues potentially involved in protein-protein interactions
Systematic mutagenesis strategy:
Alanine scanning: Replacing selected residues with alanine to remove side chain functionality
Conservative substitutions: Replacing residues with biochemically similar amino acids to probe specific interactions
Non-conservative substitutions: Introducing dramatic changes to test functional hypotheses
Domain swapping: Replacing entire functional domains with corresponding regions from related enzymes
Functional characterization of mutants:
Expression and solubility analysis to identify potentially destabilizing mutations
Thermal stability assays to quantify effects on protein stability
In vitro transglycosylase activity assays to measure catalytic effects
Substrate binding assays to distinguish between effects on binding versus catalysis
Moenomycin sensitivity to probe changes in inhibitor binding site
Data analysis and interpretation:
Classification of mutations based on their effects: catalytic, binding, structural, or regulatory
Mapping mutation effects onto structural models to identify functional hotspots
Correlation analysis between conservation level and functional importance
| Mutation Type | Target Residues | Expected Outcome | Analysis Methods |
|---|---|---|---|
| Catalytic site | Conserved active site residues | Reduced/abolished catalytic activity with preserved folding | Activity assays, CD spectroscopy |
| Substrate binding | Residues in predicted binding pocket | Altered substrate affinity (Km) with potential changes in specificity | Binding assays, kinetic analysis |
| Transmembrane domain | Hydrophobic/interface residues | Changes in membrane association or orientation affecting activity | Membrane association assays, activity in different detergents |
| Regulatory elements | Potential allosteric sites | Modified response to regulatory factors or conditions | Activity under varying conditions |
The knowledge gained through systematic mutagenesis can provide crucial insights into mtgA's catalytic mechanism, substrate specificity determinants, and potential targetable sites for antimicrobial development, while also clarifying the observed influences of the transmembrane domain on enzymatic function .
Designing rigorous inhibition studies for Bordetella avium mtgA requires careful planning to ensure reliable, reproducible, and physiologically relevant results. Key methodological considerations include:
Inhibitor selection and characterization:
Natural product inhibitors (e.g., moenomycin) as positive controls
Synthetic analogs based on substrate or transition state mimicry
Fragment-based approaches to identify novel chemical scaffolds
Complete physicochemical characterization (solubility, stability in assay conditions)
Assay optimization for inhibition studies:
Enzyme concentration adjustment to appropriate levels for inhibition detection
Substrate concentration considerations relative to Km for different inhibition mechanisms
Time course establishment to ensure measurements in the linear range
Detection method sensitivity assessment for inhibition quantification
Inhibition mechanism characterization:
Steady-state kinetic analysis with varying substrate and inhibitor concentrations
Determination of inhibition type (competitive, non-competitive, uncompetitive, mixed)
Calculation of inhibition constants (Ki, IC50) under standardized conditions
Residence time measurements for time-dependent inhibitors
Consideration of the transmembrane domain:
Selectivity profiling:
Testing against related transglycosylases to determine specificity
Counter-screening against other glycosyltransferase families
Assessment of activity against mtgA from different bacterial species
Translation to cellular systems:
Correlation between in vitro inhibition and antibacterial activity
Cell wall analysis in treated bacteria to confirm on-target effects
Resistance development studies to assess inhibitor robustness
Importantly, when designing inhibition experiments, researchers should account for the known impact of the transmembrane segment on substrate and inhibitor interactions . This may necessitate using membrane mimetic systems rather than simple aqueous buffers for more physiologically relevant inhibition assessments.
Analysis of kinetic data for Bordetella avium mtgA requires specialized approaches that account for the membrane-associated nature of both the enzyme and its lipid II substrate. A comprehensive kinetic analysis methodology includes:
Steady-state kinetic parameter determination:
Plotting initial reaction velocities against substrate concentrations
Fitting data to appropriate enzyme kinetic models:
Michaelis-Menten equation for simple kinetics
Hill equation when cooperativity is suspected
Specialized models for interfacial enzymes working on membrane surfaces
Extracting key parameters (Km, Vmax, kcat, kcat/Km) with statistical confidence intervals
Accounting for substrate depletion in membrane environments
Analysis challenges specific to transmembrane enzymes:
Correcting for detergent effects on substrate presentation and effective concentration
Accounting for substrate aggregation or micelle formation
Normalizing for active enzyme fraction, which may vary with preparation method
Consideration of the transmembrane domain's influence on activity parameters
Product analysis and processivity assessment:
Quantifying glycan chain length distribution using size exclusion chromatography or MS
Determining processivity index (average number of polymerization events per binding event)
Analyzing the kinetics of individual transglycosylation steps within processive synthesis
Data visualization and statistical analysis:
Using residual plots to assess goodness of fit and identify systematic deviations
Applying bootstrap or Monte Carlo methods to estimate parameter confidence intervals
Employing global fitting approaches for complex kinetic schemes
Comparing kinetic parameters across experimental conditions using appropriate statistical tests
When interpreting kinetic data, researchers should consider that full-length mtgA with its transmembrane segment demonstrates different kinetic properties compared to truncated versions , highlighting the importance of using appropriate protein constructs that best represent the physiological enzyme state.
Experimental design considerations:
Power analysis to determine appropriate sample sizes
Randomization strategies to minimize systematic errors
Blocking designs to account for batch effects in protein preparations
Full factorial or response surface designs for multi-parameter optimization
Data preprocessing and quality assessment:
Outlier detection and handling using statistical methods (Grubbs' test, Dixon's Q test)
Normality testing to determine appropriate parametric or non-parametric approaches
Variance homogeneity assessment (Levene's test, Bartlett's test)
Transformation strategies when distribution assumptions are violated
Comparative analysis methods:
Student's t-test or Welch's t-test for two-condition comparisons
ANOVA with appropriate post-hoc tests for multi-condition experiments
Non-parametric alternatives (Mann-Whitney U, Kruskal-Wallis) when assumptions are violated
Mixed-effects models for handling repeated measurements and nested designs
Specialized methods for enzyme kinetics:
Non-linear regression with appropriate weighting schemes
Global fitting approaches for complex kinetic mechanisms
Bootstrap or jackknife resampling for parameter uncertainty estimation
Akaike Information Criterion (AIC) or Bayesian Information Criterion (BIC) for model selection
Handling contradictions and inconsistencies:
Reporting standards:
Complete disclosure of statistical methods, including software packages and versions
Reporting of effect sizes and confidence intervals, not just p-values
Clear distinction between exploratory and confirmatory analyses
Sharing of raw data and analysis code for reproducibility
When applying these statistical approaches, researchers should be particularly attentive to the impact of experimental conditions on mtgA activity, especially considering the demonstrated influence of the transmembrane domain on enzymatic function . This may require specialized statistical approaches that account for the added variability introduced by membrane-associated proteins and their reconstitution systems.
Structural biology techniques provide powerful insights into the molecular mechanisms of Bordetella avium mtgA function. Methodological approaches and their applications include:
The implementation of these approaches should consider the demonstrated importance of the transmembrane segment to mtgA function . Structural biology studies should ideally include the full-length protein whenever possible, or explicitly acknowledge the limitations of using truncated constructs that may not fully recapitulate native functional properties.